Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News Alert: HeartFlow announces plans to merge, go public in deal worth $2.4B

News You Need to Know Today
News Alert: HeartFlow announces plans to merge, go public in deal worth $2.4B
Friday, July 16, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

HeartFlow announces plans to merge, go public in deal worth $2.4B

Once the transaction is finalized, the combined entity will go by the name HeartFlow Group and be listed on the New York Stock Exchange as “HFLO.”

READ MORE >
private equity corporatization business consolidation
Share on Twitter Share on Facebook Share on Linkedin

HeartFlow announces plans to merge, go public in deal worth $2.4B

Share on Twitter Share on Facebook Share on Linkedin
private equity corporatization business consolidation
Once the transaction is finalized, the combined entity will go by the name HeartFlow Group and be listed on the New York Stock Exchange as “HFLO.”
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiology practice pays $3.5M in data breach settlement | Key ACC trials | More screening, treatment needed for CKD
Software errors lead to major insulin pump recall | FDA approves another GLP-1 pill | Premature menopause & the heart
Hospital sues cardiology practice | Cardiologist fired for speaking out, lawsuit claims | FDA approves another GLP-1 pill
Week in Review: ‘Practice-changing’ cardiology research | Another Impella recall | FDA clears AI for pulmonary hypertension
Innovations at ACC 2026 | Lower drug costs increase medication compliance | TAVR temporary pacing lead cleared by FDA
March's Top Stories: 40 Under 40 | Court affirms death sentence for Texas nurse | Recreational Adderall use | TAVR innovation
Key takeaways from ACC.26 | FDA confirms recall for heart pumps | AI alerts deliver value | Practice adds in-house smart lab

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …13
    • Page 14
    • Page 15
    • Page 16
    • Current page 17
    • Page 18
    • Page 19
    • Page 20
    • Page 21 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme